Association between initial systolic blood pressure and risk of developing a uremic crisis or of dying in dogs with chronic renal failure

Journal of the American Veterinary Medical Association

Volumn 222, Issue 3, 2003, Pages 322-329

  Jacob, Frédéric ^a,d   Polzin, David J ^a   Osborne, Carl A ^a   Neaton, James D ^b   Lekcharoensuk, Chalermpol ^a   Allen, Timothy A ^c   Kirk, Claudia A ^c   Swanson, Laurie L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Hill's Pet Nutrition Inc   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE BESYLATE; ANTIHYPERTENSIVE AGENT; CREATININE; DILTIAZEM; ENALAPRIL MALEATE;

ANIMAL DISEASE; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DOG; FEMALE; HYPERTENSION; HYPERTENSION ENCEPHALOPATHY; HYPERTENSION RETINOPATHY; KIDNEY FUNCTION; MALE; MORTALITY; NONHUMAN; RISK ASSESSMENT; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; UREMIA; VETERINARY MEDICINE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COHORT STUDIES; CREATININE; DOG DISEASES; DOGS; HYPERTENSION; HYPERTENSIVE ENCEPHALOPATHY; KIDNEY FAILURE, CHRONIC; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RETINAL DISEASES; RISK FACTORS; SURVIVAL ANALYSIS; UREMIA;

ANIMALIA; CANIS FAMILIARIS;

EID: 0037306715     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2003.222.322     Document Type: Article

References (38)

1. Van Den Hoogen PC, Feskens EM, Naglekerke NJ, et al. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. N Engl J Med 2000;342:1-8.
2. MacMahon S., Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-774.
3. Stamler J, Dyer AR, Shekelle RB, et al. Relationship of base line major risk factors to coronary and all cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts. Cardiology 1993;82:191-222.
4. Bovée KC. Current status of systemic hypertension in the dog, in Proceedings. 16th Waltham/OSU Symp 1992;17-22.
5. Littman MP. Update: treatment of hypertension in dogs and cats. In: Kirk RW, ed. Current veterinary therapy XI. Philadelphia: WB Saunders Co, 1992;838-841.
6. Cowgill LD, Kallet AJ. Systemic hypertension. In: Kirk RW, ed. Current veterinary therapy IX. Philadelphia: WB Saunders Co, 1986;360-364.
7. Ross LA. Hypertension and chronic renal failure. Semin Vet Med Surg Small Anim 1992;7:221-226.
8. Paulsen ME, Allen TA, Jaenke RS, et al. Arterial hypertension in two canine siblings: ocular and systemic manifestations. J AM Anim Hosp Assoc 1989;25:287-295.
9. Gwin RM, Gelatt KN, Terrell TG, et al. Hypertensive retinopathy associated with hypothyroidism, hypercholesterolemia, and renal failure in a dog. J Am Anim Hosp Assoc 1978;14:200-209.
10. Bovée KC, Littman MP, Crabtree BJ, et al. Essential hypertension in a dog. J Am Vet Med Assoc 1989;195:81-86.
11. Littman MP, Robertson JL, Bovée KC. Spontaneous systemic hypertension in dogs: five cases (1981-1983). J Am Vet Med Assoc 1988;193:486-494.
12. Bartges JW, Willis MS, Polzin DJ. Hypertension and renal disease. Vet Clin North Am Small Amin Pract 1996;26:1331-1345.
13. Kannel W. Hypertension and global cardiovascular risk. In: Izzo JH, Black HR, eds. Hypertension primier. Chicago: American Heart Association, 1993;199-202.
14. Hostetter TH. Progression of renal disease. In: Greenberg A, ed. Primer on kidney diseases. 2nd ed. San Diego: Academic Press Inc, 1998;429-432.
15. Brazy PC, Stead WW, Fitzwilliam JF. Progression of renal insufficiency: role of blood pressure. Kidney Int 1989;35:670-674.
16. Sundock BA, Whisnant JP. Hypertension and the brain: clinical aspect. In: Genest J, Kuchel O, Hamet P, et al, eds. Hypertension. 2nd ed. New York: McGraw-Hill Book Co, 1983;777-791.
17. Sansom J, Bodey A. Ocular signs in four dogs with hypertension. Vet Rec 1997;140:593-598.
18. Jacob F, Polzin DJ, Osborne CA, et al. Clinical evaluation of dietary modification for treatment of spontaneous chronic renal failure in dogs. J Am Vet Med Assoc 2002;220:1163-1170.
19. Bodey AR, Michell AR. Longitudinal studies of reproducibility and variability of indirect (oscillometric) blood pressure measurements in dogs: evidence for tracking. Res Vet Sci 1997;63:15-21.
20. Mishina M, Watanabe T, Fugii K, et al. A clinical evaluation of blood pressure through non-invasive measurement using the oscillometric procedure in conscious dogs. J Vet Med Sci 1997;59:987-993.
21. Lott JA, Stephan VA, Pritchard KA. Evaluation of Coomassie brilliant blue G-250 method for urinary protein. Clin Chem 1983;29:1946-1950.
22. Cannon DC. Kidney function test. In: Henry RJ, Cannon DC, Winkelman JW, eds. Clinical chemistry. 2nd ed. Philadelphia: Harper & Row, 1974;1535-1554.
23. Allen TA, Jaenke RS, Fettman MJ. A technique for estimating progression of chronic renal failure in the dog. J Am Vet Med Assoc 1987;190:866-868.
24. Snedecor GW, Cochran WG. The rank sum test for two independent samples. In: Statistical methods. 8th ed. Ames, Iowa: Iowa State Press University, 1989;142-144.
25. Glantz SA. How to analyze survival data. In: Glantz SA, ed. Primer of biostatistics. 4th ed. New York: McGraw-Hill Book Co, 1997;373-402.
26. Meier P. Anatomy and interpretation of Cox regression model. ASAIO J 1985;8:3-12.
27. Peterson JC, Adler S, Burkart JM, et al. Blood pressure control, proteinuria, and the progression of renal disease. The modification of diet in renal disease study. Ann Intern Med 1995;123:754-762.
28. Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. N Engl J Med 1988;318:1657-1666.
29. Sievers ML, Bennet PH, Roumain J. Effect of hypertension on mortality in Pima Indians. Circulation 1999;100:33-40.
30. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996;334:13-18.
31. Heidbreder E, Huller U, Schafer B, et al. Severe hypertensive retinopathy. Am J Nephrol 1987;7:394-400.
32. Finco DR, Brown SA, Brown CA, et al. Progression of chronic renal disease in the dog. J Vet Intern Med 1999;13:516-528.
33. Finco DR, Brown SA, Vaden S, et al. Relationship between plasma creatinine concentrations and glomerular filtration in dogs. J Vet Pharrnacol Ther 1995;18:418-421.
34. Grauer GF, Greco DS, Getzy DM, et al. Effects of enalapril versus placebo as a treatment for canine idiopathic glomerulonephritis. J Vet Intern Med 2000;14:526-533.
35. Schwenger V, Zeier M, Ritz E. Antihypertensive therapy in renal patients - benefits and difficulties. Nephron 1990;83:202-213.
36. Weir MR, Dworkin LD. Antihypertensive drugs, dietary salt, and renal protection: how low should we go and with which therapy? Am J Kidney Dis 1998;32:1-22.
37. Lazarus JM, Bourgoignie JJ, Buckalew VM, et al. Achievement and safety of low blood pressure goal in chronic renal disease: modification of diet in renal disease study group. Hypertension 1997;29:641-650.
38. Brown SA, Walton CL, Crawford P, et al. Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria. Kidney Int 1993;43:1210-1218.